A dominant human pathogenic amino-acid mutation in the VCP (valosine containing protein) gene results in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD) and ALS, but the same heterozygous mutation has little effect in mice28. Here, VCP is linked to inclusion body myopathy with Paget disease of bone and frontotemporal dementia.